Reference health

The role of 20-HETE in androgen-mediated hypertension

https://doi.org/10.1016/j.prostaglandins.2011.06.006
CiteStamped reference-health badge
1 of 120 checkable references need attention · checked 2026-07-23

At the dated check, the references listed below either did not resolve in Crossref or DataCite, or carried a retraction notice. Each one is shown with the registry record that put it there.

5 without a DOI — not checked. A reference deposited without a DOI is never matched by title or guessed at; it stays outside the checked set, and this line discloses that.

References needing attention

marked retracted — notice via Crossref, record curated by Retraction Watch10.1210/jc.2007-0425
Withdrawn: Postmenopausal Women with a History of Irregular Menses and Elevated Androgen Measurements at High Risk for Worsening Cardiovascular Event-Free Survival: Results from the National Institutes of Health—National Heart, Lung, and Blood Institute Sponsored Women’s Ischemia Syndrome Evaluation
The 119 checked references that resolve
resolves10.1161/01.HYP.37.5.1199
Gender Differences in the Regulation of Blood Pressure
resolves10.1161/01.HYP.25.3.305
Prevalence of Hypertension in the US Adult Population
resolves10.1161/HYPERTENSIONAHA.107.105742
Menopause and Hypertension
resolves10.1016/j.amjmed.2008.04.026
Sex Differences in Environmental and Genetic Factors for Hypertension
resolves10.1210/er.2003-0005
Androgens and Cardiovascular Disease
resolves10.1161/01.HYP.0000124670.03674.15
Novel Mechanisms Responsible for Postmenopausal Hypertension
resolves10.1159/000119417
Testosterone and Blood Pressure Regulation
resolves10.1016/0024-3205(91)90428-E
Sexual dimorphism of blood pressure in spontaneously hypertensive rats is androgen dependent
resolves10.1161/01.HYP.35.1.480
Gender Differences in Development of Hypertension in Spontaneously Hypertensive Rats
resolves10.1161/01.HYP.31.1.435
Testosterone Exacerbates Hypertension and Reduces Pressure-Natriuresis in Male Spontaneously Hypertensive Rats
resolves10.1097/00004872-199310000-00005
Role of vasopressin, the renin???angiotensin system and sex in Dahl salt-sensitive hypertension
resolves10.1161/01.HYP.29.1.494
Gonadal Hormones Modulate Deoxycorticosterone-Salt Hypertension in Male and Female Rats
resolves10.1161/01.HYP.9.2.172
Sex difference in the development of deoxycorticosterone-salt hypertension in the rat.
resolves10.1530/acta.0.1240091
Sexual dimorphism in renal function and hormonal status of New Zealand genetically hypertensive rats
resolves10.1073/pnas.081627898
Alterations in the regulation of androgen-sensitive Cyp 4a monooxygenases cause hypertension
resolves10.1016/0895-7061(95)00216-2
24-h ambulatory blood pressure in 352 normal Danish subjects, related to age and gender*
resolves10.1038/ajh.2011.71
Postmenopausal Hypertension
resolves10.1038/sj.jhh.1000481
Serum sex hormone levels in postmenopausal women with hypertension
resolves10.1159/000194971
Obesity and Polycystic Ovary Syndrome
resolves10.1161/01.HYP.0000112224.87290.3a
20-HETE and Circulating Insulin in Essential Hypertension With Obesity
resolves10.1016/j.diabres.2006.04.001
20-Hydroxyeicosatetraenoic acid is not associated with circulating insulin in lean to overweight humans
resolves10.1016/j.amjcard.2010.05.013
Cardiac and Metabolic Effects of Anabolic-Androgenic Steroid Abuse on Lipids, Blood Pressure, Left Ventricular Dimensions, and Rhythm
resolves10.1136/hrt.2003.015719
Are the cardiac effects of anabolic steroid abuse in strength athletes reversible?
resolves10.1530/EJE-10-0951
Metabolic syndrome and the effect of testosterone treatment in young men with congenital hypogonadotropic hypogonadism
resolves10.1210/jc.2005-1398
Vascular Reactivity in Congenital Hypogonadal Men before and after Testosterone Replacement Therapy
resolves10.1111/j.1447-0756.2008.00857.x
Increased arterial stiffness in female‐to‐male transsexuals treated with androgen
resolves10.1097/FJC.0b013e3181f04b1c
20-Hydroxyeicosatetraeonic Acid: A New Target for the Treatment of Hypertension
resolves10.1161/HYPERTENSIONAHA.107.089599
Vascular Cytochrome P450 4A Expression and 20-Hydroxyeicosatetraenoic Acid Synthesis Contribute to Endothelial Dysfunction in Androgen-Induced Hypertension
resolves10.1161/HYPERTENSIONAHA.110.161570
Androgen-Dependent Hypertension Is Mediated by 20-Hydroxy-5,8,11,14-Eicosatetraenoic Acid–Induced Vascular Dysfunction
resolves10.1152/ajpregu.00459.2002
Androgen-mediated induction of the kidney arachidonate hydroxylases is associated with the development of hypertension
resolves10.1080/03602530701468573
Human Cytochrome P450 Family 4 Enzymes: Function, Genetic Variation and Regulation
resolves10.1096/fasebj.6.2.1537463
Cytochrome P450 and the arachidonate cascade <sup>1</sup>
resolves10.1146/annurev.pharmtox.45.120403.100045
REGULATION AND INHIBITION OF ARACHIDONIC ACID ω-HYDROXYLASES AND 20-HETE FORMATION
resolves10.1016/j.bcp.2008.03.004
Cytochrome P450 omega hydroxylase (CYP4) function in fatty acid metabolism and metabolic diseases
resolves10.1016/j.pharmthera.2006.03.008
Cytochrome P450 4F subfamily: At the crossroads of eicosanoid and drug metabolism
resolves10.1074/jbc.275.6.4118
Formation of 20-Hydroxyeicosatetraenoic Acid, a Vasoactive and Natriuretic Eicosanoid, in Human Kidney
resolves10.1161/01.CIR.0000151309.82473.59
Functional Variant of <i>CYP4A11</i> 20-Hydroxyeicosatetraenoic Acid Synthase Is Associated With Essential Hypertension
resolves10.1124/jpet.103.059626
Catalytic Activity and Isoform-Specific Inhibition of Rat Cytochrome P450 4F Enzymes
resolves10.1042/BJ20061328
Mouse Cyp4a isoforms: enzymatic properties, gender- and strain-specific expression, and role in renal 20-hydroxyeicosatetraenoic acid formation
resolves10.1152/ajprenal.00132.2002
Distribution of cytochrome<i>P</i>-450 4A and 4F isoforms along the nephron in mice
resolves10.1540/jsmr.41.175
Role of 20-hydroxyeicosatetraenoic acid (20-HETE) in vascular system
resolves10.1152/physrev.00021.2001
<i>P</i>-450 Metabolites of Arachidonic Acid in the Control of Cardiovascular Function
resolves10.1016/j.freeradbiomed.2007.03.004
A reduction in alcohol consumption is associated with reduced plasma F2-isoprostanes and urinary 20-HETE excretion in men
resolves10.1016/j.freeradbiomed.2004.12.024
Urinary 20-hydroxyeicosatetraenoic acid excretion is associated with oxidative stress in hypertensive subjects
resolves10.1161/01.CIR.0000136808.72912.D9
Urinary 20-Hydroxyeicosatetraenoic Acid Is Associated With Endothelial Dysfunction in Humans
resolves10.1681/ASN.2007060713
Association of a Functional Cytochrome P450 4F2 Haplotype with Urinary 20-HETE and Hypertension
resolves10.1161/HYPERTENSIONAHA.107.104463
A Single Nucleotide Polymorphism in the <i>CYP4F2</i> but not <i>CYP4A11</i> Gene Is Associated With Increased 20-HETE Excretion and Blood Pressure
resolves10.1161/HYPERTENSIONAHA.108.114199
The V433M Variant of the <i>CYP4F2</i> Is Associated With Ischemic Stroke in Male Swedes Beyond Its Effect on Blood Pressure
resolves10.1182/blood.V78.6.1461.1461
Modulation of erythropoiesis by novel human bone marrow cytochrome P450- dependent metabolites of arachidonic acid
resolves10.1002/bms.1200210505
Quantitation of 20-hydroxy-5,8,11,14-eicosatetraenoic acid (20-HETE) produced by human polymorphonuclear leukocytes using electron capture ionization gas chromatography/mass spectrometry
resolves10.1152/japplphysiol.01159.2001
CYP4A mRNA, protein, and product in rat lungs: novel localization in vascular endothelium
resolves10.1152/ajprenal.00265.2001
Cytochrome<i>P</i>-450 4A isoform expression and 20-HETE synthesis in renal preglomerular arteries
resolves10.1016/S0022-3565(25)23636-9
Vasoactivity of 20-hydroxyeicosatetraenoic acid is dependent on metabolism by cyclooxygenase.
resolves10.1161/CIRCRESAHA.108.193227
Synergistic Activation of Vascular TRPC6 Channel by Receptor and Mechanical Stimulation via Phospholipase C/Diacylglycerol and Phospholipase A <sub>2</sub> /ω-Hydroxylase/20-HETE Pathways
resolves10.1161/01.HYP.0000047240.33861.6B
20-HETE–Induced Contraction of Small Coronary Arteries Depends on the Activation of Rho-Kinase
resolves10.1152/ajprenal.00249.2002
Transfection of CYP4A1 cDNA increases vascular reactivity in renal interlobar arteries
resolves10.1152/ajpregu.2001.280.1.R255
CYP4A1 antisense oligonucleotide reduces mesenteric vascular reactivity and blood pressure in SHR
resolves10.1152/ajpheart.00627.2003
Transfection of CYP4A1 cDNA decreases diameter and increases responsiveness of gracilis muscle arterioles to constrictor stimuli
resolves10.1161/hy1201.096116
Modulation by 20-HETE of Phenylephrine-Induced Mesenteric Artery Contraction in Spontaneously Hypertensive and Wistar-Kyoto Rats
resolves10.1161/01.HYP.22.3.357
Elevated renovascular tone in young spontaneously hypertensive rats. Role of cytochrome P-450.
resolves10.1152/ajprenal.00364.2009
Endothelial-specific CYP4A2 overexpression leads to renal injury and hypertension via increased production of 20-HETE
resolves10.1161/01.RES.87.10.840
Endothelial Dysfunction in Cardiovascular Diseases: The Role of Oxidant Stress
resolves10.1152/ajpheart.2000.278.5.H1517
Contribution of cytochrome<i>P</i>-450 ω-hydroxylase to altered arteriolar reactivity with high-salt diet and hypertension
resolves10.1152/japplphysiol.00247.2002
Nitric oxide contributes to 20-HETE-induced relaxation of pulmonary arteries
resolves10.1152/ajplung.00424.2005
Mechanisms of activation of eNOS by 20-HETE and VEGF in bovine pulmonary artery endothelial cells
resolves10.1161/01.RES.0000217283.98806.a6
Endothelial Dysfunction and Hypertension in Rats Transduced With CYP4A2 Adenovirus
resolves10.1152/ajpheart.01172.2007
20-Hydroxyeicosatetraenoic acid causes endothelial dysfunction via eNOS uncoupling
resolves10.1124/jpet.109.159863
20-Hydroxy-5,8,11,14-eicosatetraenoic Acid Mediates Endothelial Dysfunction via IκB Kinase-Dependent Endothelial Nitric-Oxide Synthase Uncoupling
resolves10.1111/j.1440-1681.2011.05509.x
Chronic activation of AMP‐activated protein kinase prevents 20‐hydroxyeicosatetraenoic acid‐induced endothelial dysfunction
resolves10.1152/ajpheart.00512.2008
Elevated production of 20-HETE in the cerebral vasculature contributes to severity of ischemic stroke and oxidative stress in spontaneously hypertensive rats
resolves10.1097/00004872-200502000-00002
Small artery structure and hypertension: adaptive changes and target organ damage
resolves10.1016/j.amjhyper.2004.05.023
Remodeling of resistance arteries in essential hypertension and effects of antihypertensive treatment
resolves10.1016/j.tips.2008.05.003
Role of the renin–angiotensin system in vascular inflammation
resolves10.1161/01.CIR.0000089190.95415.9F
New Markers of Inflammation and Endothelial Cell Activation
resolves10.1089/ars.2007.2007
Reactive Oxygen Species and Endothelial Activation
resolves10.1160/TH07-02-0085
Chemokines in vascular remodeling
resolves10.1007/s00395-008-0733-0
The role of inflammatory cytokines in endothelial dysfunction
resolves10.1084/jem.20070657
Role of the T cell in the genesis of angiotensin II–induced hypertension and vascular dysfunction
resolves10.1161/HYPERTENSIONAHA.108.112706
Role of Inflammation in the Development of Renal Damage and Dysfunction in Angiotensin II–Induced Hypertension
resolves10.1161/HYPERTENSIONAHA.110.163576
Inflammation, Immunity, and Hypertension
resolves10.1152/japplphysiol.90470.2008
Inflammation and endothelial dysfunction during aging: role of NF-κB
resolves10.1016/S0092-8674(00)81694-3
IκB–NF-κB Structures
resolves10.1152/ajpheart.01346.2006
Increased mitochondrial H<sub>2</sub>O<sub>2</sub> production promotes endothelial NF-κB activation in aged rat arteries
resolves10.1016/j.exger.2006.04.005
Amelioration of age-related inflammation and oxidative stress by PPARγ activator: Suppression of NF-κB by 2,4-thiazolidinedione
resolves10.1161/01.RES.0000269183.13937.e8
Direct Evidence of Endothelial Oxidative Stress With Aging in Humans
resolves10.1089/ars.2006.8.572
The Molecular Inflammatory Process in Aging
resolves10.1161/01.ATV.0000160340.72641.87
Nuclear Factor κB Signaling in Atherogenesis
resolves10.1042/CS20060247
Vascular inflammation in hypertension and diabetes: molecular mechanisms and therapeutic interventions
resolves10.1186/1471-2261-2-3
Angiotensin II induced inflammation in the kidney and in the heart of double transgenic rats
resolves10.1161/CIRCRESAHA.107.150474
Vascular Endothelial Cell–Specific NF-κB Suppression Attenuates Hypertension-Induced Renal Damage
resolves10.1124/jpet.107.130336
20-Hydroxyeicosatetraenoic Acid Stimulates Nuclear Factor-κB Activation and the Production of Inflammatory Cytokines in Human Endothelial Cells
resolves10.1124/jpet.106.115360
Activation of Vascular Endothelial Growth Factor through Reactive Oxygen Species Mediates 20-Hydroxyeicosatetraenoic Acid-Induced Endothelial Cell Proliferation
resolves10.1152/ajplung.00278.2007
20-HETE increases superoxide production and activates NAPDH oxidase in pulmonary artery endothelial cells
resolves10.1152/ajpheart.00874.2008
20-HETE can act as a nonhypoxic regulator of HIF-1α in human microvascular endothelial cells
resolves10.1097/MNH.0b013e3282f2fd39
Targeting genes in the renin–angiotensin system
resolves10.1046/j.1523-1755.2000.057003863.x
Understanding hypertension through genetic manipulation in mice
resolves10.1152/ajprenal.2000.279.3.F544
Angiotensin II releases 20-HETE from rat renal microvessels
resolves10.1152/ajpregu.00664.2001
Role of 20-hydroxyeicosatetraenoic acid in the renal and vasoconstrictor actions of angiotensin II
resolves10.1152/ajpregu.00401.2005
Increased renal vascular reactivity to ANG II after unilateral nephrectomy in the rat involves 20-HETE
resolves10.1016/j.vph.2007.05.005
Effects of chronic cytochrome P-450 inhibition on the course of hypertension and end-organ damage in Ren-2 transgenic rats
resolves10.1161/01.HYP.36.4.604
Angiotensin II–Induced Hypertension
resolves10.1161/01.HYP.37.2.623
20-Hydroxyeicosatetraenoic Acid Mediates Angiotensin II–Induced Phospholipase D Activation in Vascular Smooth Muscle Cells
resolves10.1161/01.HYP.0000168051.04275.ea
Contribution of Arachidonic Acid Metabolites Derived Via Cytochrome P4504A to Angiotensin II–Induced Neointimal Growth
resolves10.1161/HYPERTENSIONAHA.110.154559
CYP4A2-Induced Hypertension Is 20-Hydroxyeicosatetraenoic Acid– and Angiotensin II–Dependent
resolves10.1126/science.2492116
Treatment with Tin Prevents the Development of Hypertension in Spontaneously Hypertensive Rats
resolves10.1258/ebm.2010.009233
Renal function and vasomotor activity in mice lacking the Cyp4a14 gene
resolves10.1016/j.pharmthera.2009.12.002
Effect of cytochrome P450 polymorphism on arachidonic acid metabolism and their impact on cardiovascular diseases
resolves10.1681/ASN.2008010063
Association of a CYP4A11 Variant and Blood Pressure in Black Men
resolves10.1161/HYPERTENSIONAHA.107.102921
The T8590C Polymorphism of CYP4A11 and 20-Hydroxyeicosatetraenoic Acid in Essential Hypertension
resolves10.1038/ajh.2008.276
A Haplotype of the CYP4F2 Gene is Associated With Cerebral Infarction in Japanese Men
resolves10.1291/hypres.31.1719
Haplotype-Based Case-Control Study of the Human CYP4F2 Gene and Essential Hypertension in Japanese Subjects
resolves10.1016/j.ymgme.2008.11.161
A haplotype of the CYP4F2 gene associated with myocardial infarction in Japanese men
resolves10.1097/01.hjh.0000244944.34546.8e
Association of a functional polymorphism in the CYP4A11 gene with systolic blood pressure in survivors of myocardial infarction
resolves10.1097/HJH.0b013e3282f2f10c
A haplotype of the CYP4A11 gene associated with essential hypertension in Japanese men
resolves10.1152/physiolgenomics.00003.2007
Functional polymorphism in human CYP4F2 decreases 20-HETE production
resolves10.1097/HJH.0b013e328342673c
Peripheral and central augmentation indexes in relation to the CYP4F2 polymorphisms in Chinese
resolves10.1161/01.HYP.0000151825.36598.36
Sex Steroids, Cardiovascular Disease, and Hypertension
resolves10.1152/ajpregu.00387.2010
Postmenopausal hypertension: role of 20-HETE
resolves10.1073/pnas.95.21.12701
20-Hydroxyeicosatetraenoic acid mediates calcium/calmodulin-dependent protein kinase II-induced mitogen-activated protein kinase activation in vascular smooth muscle cells
The 5 references without a DOI — listed, not checked
no DOI — not checkedRenal vascular cytochrome P450-derived eicosanoids in androgen-induced hypertension
no DOI — not checkedThe effect of gender on age-related blood pressure changes and the prevalence of isolated systolic hypertension among older adults: data from NHANES III
no DOI — not checkedJi H, Zheng W, Wu X, et al. Sex chromosome effects unmasked in angiotensin II-induced hypertension. Hypertension.
no DOI — not checkedKinetic profile of the rat CYP4A isoforms: arachidonic acid metabolism and isoform-specific inhibitors
no DOI — not checked20-HETE is an endogenous inhibitor of the large-conductance Ca2+-activated K+ channel in renal arterioles
What this badge says. CiteStamped means the CHECKABLE references of this work were clean at the dated check: each resolved to a known work in a public registry, and none carried a retraction notice at that time. It says nothing about the quality, findings, or importance of the work itself, and nothing about references deposited without a DOI.

checked 2026-07-23 — re-checked daily as this page is visited; titles and statuses come from Crossref and DataCite and are not part of the signed record

Embed this badge

Both snippets point at the live badge image and link back to this page. The badge re-renders from the daily check, so an embed never goes stale by more than a day of visits.

<a href="https://citestamp.com/citestamped/10.1016/j.prostaglandins.2011.06.006"><img src="https://citestamp.com/citestamped/10.1016/j.prostaglandins.2011.06.006/badge.svg" alt="CiteStamped reference-health badge" width="460" height="64"></a>
[![CiteStamped reference-health badge](https://citestamp.com/citestamped/10.1016/j.prostaglandins.2011.06.006/badge.svg)](https://citestamp.com/citestamped/10.1016/j.prostaglandins.2011.06.006)